Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hoes LR"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours.
Autorzy:
Geurts BS; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Battaglia TW; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
van Berge Henegouwen JM; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.
Zeverijn LJ; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
de Wit GF; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
Hoes LR; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.
van der Wijngaart H; Oncode Institute, Utrecht, the Netherlands.; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.
van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Roepman P; Hartwig Medical Foundation, Amsterdam, the Netherlands.
de Leng WWJ; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.
Jansen AML; Department of Pathology, University Medical Cancer Centre Utrecht, Utrecht, the Netherlands.
Opdam FL; Department of Clinical Pharmacology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
de Jonge MJA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Cirkel GA; Department of Medical Oncology, Meander, Amersfoort, the Netherlands.
Labots M; Department of Medical Oncology, Amsterdam University Medical Centre, location VUMC, Amsterdam, the Netherlands.
Hoeben A; Department of Medical Oncology, Department of Internal Medicine, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Kerver ED; Department of Medical Oncology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
Bins AD; Department of Medical Oncology, Amsterdam University Medical Centre, location AUMC, Amsterdam, the Netherlands.
Erdkamp FGL; Department of Medical Oncology, Zuyderland Hospital, Sittard-Geelen, the Netherlands.
van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.
Houtsma D; Department of Medical Oncology, Haga Hospital, The Hague, the Netherlands.
Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.
de Groot JB; Department of Medical Oncology, Isala, Zwolle, the Netherlands.
Verheul HMW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.
Voest EE; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands. .; Oncode Institute, Utrecht, the Netherlands. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 04; Vol. 23 (1), pp. 205. Date of Electronic Publication: 2023 Mar 04.
Typ publikacji:
Journal Article
MeSH Terms:
Microsatellite Instability*
Brain Neoplasms*
Humans ; Biomarkers
SCR Disease Name:
Turcot syndrome
Czasopismo naukowe
Tytuł:
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE).
Autorzy:
Samsom KG; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bosch LJW; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Schipper LJ; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Roepman P; Hartwig Medical Foundation, Amsterdam, The Netherlands.
de Bruijn E; Hartwig Medical Foundation, Amsterdam, The Netherlands.
Hoes LR; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Riethorst I; Hartwig Medical Foundation, Amsterdam, The Netherlands.
Schoenmaker L; Hartwig Medical Foundation, Amsterdam, The Netherlands.
van der Kolk LE; Family Cancer Clinic, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Retèl VP
Frederix GWJ
Buffart TE; Department of Gastrointestinal Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
van der Hoeven JJM; Hartwig Medical Foundation, Amsterdam, The Netherlands.
Voest EE; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.
Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands.; Center for Molecular Medicine and Oncode Institute, University Medical Center Utrecht, Utrecht, The Netherlands.
Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. .
Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2020 Nov 10; Vol. 13 (1), pp. 169. Date of Electronic Publication: 2020 Nov 10.
Typ publikacji:
Clinical Trial Protocol; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms:
Molecular Diagnostic Techniques*/economics
Molecular Diagnostic Techniques*/methods
Whole Genome Sequencing*/economics
Whole Genome Sequencing*/methods
Neoplasms/*diagnosis
Precision Medicine/*methods
Biomarkers, Tumor/analysis ; Biomarkers, Tumor/genetics ; Clinical Decision-Making ; DNA, Neoplasm/genetics ; Feasibility Studies ; Humans ; Neoplasms/chemistry ; Neoplasms/genetics ; Observational Studies as Topic ; Patient Selection ; Research Design ; Specimen Handling/methods ; Standard of Care ; Technology Assessment, Biomedical ; Workflow
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies